Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

GCP Risk-based Monitoring

Session Chair(s)

Kathy  Goin, MS

Kathy Goin, MS

Vice President, Clinical Operations

Trevena Inc., United States

Mission Possible: Creating a Trial Quality Profile

Learning Objective : Discuss attitudes and expectations of research personnel with regard to monitoring within the context of the new FDA "Guidance for Industry Oversight of Clinical Investigations"; Identify and analyze trial metrics to improve quality and performance; Discuss how to develop a trial quality profile; Define how to obtain support for and implement risk-based monitoring strategies.

Speaker(s)

Penelope K. Manasco, MD, MS

Mission Possible: Creating a Trial Quality Profile

Penelope K. Manasco, MD, MS

MANA RBM , United States

Chief Executive Officer

Kathy  Goin, MS

Like a Fine Wine, Risk-based Monitoring Approaches Take Time

Kathy Goin, MS

Trevena Inc., United States

Vice President, Clinical Operations

Sherri Ann Hubby

New Monitoring Approaches: Evolution or Revolution?

Sherri Ann Hubby

Myovant Sciences , United States

Senior Director, GCP Quality Assurance

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.